Polyclonal Rabbit anti‑Human NANOG Antibody (Ser285, IF, WB) LS‑C323224
Polyclonal Rabbit anti‑Human NANOG Antibody (Ser285, IF, WB) LS‑C323224
Antibody:
NANOG Rabbit anti-Human Polyclonal (Ser285) Antibody
Format:
Unconjugated, Unmodified
Overview
Antibody:
NANOG Rabbit anti-Human Polyclonal (Ser285) Antibody
Format:
Unconjugated, Unmodified
Specifications
Description
NANOG antibody LS-C323224 is an unconjugated rabbit polyclonal antibody to human NANOG (Ser285). Validated for IF and WB.
Target
Human NANOG
Synonyms
NANOG | Nanog homeobox | NANOGP8 | HNanog | Homeobox protein NANOG
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated.
Also available conjugated with
APC,
FITC,
HRP,
PE,
Biotin.
Purification
Affinity purified
Modifications
Unmodified.
Also available
Azide-free.
Specificity
This NANOG antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 267-292 amino acids from human NANOG.
Applications
- Immunofluorescence (1:10 - 1:50)
- Western blot (1:1000)
Presentation
PBS, pH 7.2, 0.09% Sodium Azide
Storage
Short term: store at 4°C. Long term: store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
IHC, IHC - Paraffin, Immunofluorescence, Western blot, Flow Cytometry
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot, ELISA, Peptide Enzyme-Linked Immunosorbent Assay
Species:
Human
Applications:
Immunofluorescence, Western blot, ELISA
Species:
Human, Monkey
Applications:
IHC, Immunofluorescence, Western blot, ELISA, Peptide Enzyme-Linked Immunosorbent Assay
Species:
Human
Applications:
Western blot, ELISA
Species:
Human
Applications:
Western blot, ELISA
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/20/2024